• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名新冠肺炎患者甲状腺切除术后的低钙血症:病例报告及文献综述

Hypocalcemia Following Thyroidectomy in a Patient With COVID-19: A Case Report and Literature Review.

作者信息

Inoue Takahiro, Kumai Takumi, Ohara Kenzo, Takahara Miki

机构信息

Department of Otolaryngology - Head and Neck Surgery, Asahikawa Medical University, Asahikawa, JPN.

出版信息

Cureus. 2024 Aug 12;16(8):e66665. doi: 10.7759/cureus.66665. eCollection 2024 Aug.

DOI:10.7759/cureus.66665
PMID:39262524
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11390140/
Abstract

COVID-19 can lead to various complications, including severe respiratory symptoms. Both viral infections and total thyroidectomy are known to cause hypocalcemia, making a history of thyroidectomy a potential risk factor for hypocalcemia in COVID-19 patients. We present the case of a 34-year-old woman with Graves' disease who developed hypocalcemia due to COVID-19 following a total thyroidectomy. The patient underwent an uneventful total thyroidectomy, with preservation of at least three of the four parathyroid glands. Postoperatively, her parathyroid hormone (PTH) levels were normal, and she was discharged without tetany. However, on postoperative day 90, she experienced mild hypocalcemia during a COVID-19 infection, although it was asymptomatic. By postoperative day 127, she presented with severe tetany and general malaise. Testing confirmed a reinfection with SARS-CoV-2 and hypocalcemia, while PTH levels remained normal. Treatment with intravenous calcium gluconate, oral calcium lactate, and alfacalcidol effectively resolved the hypocalcemia and tetany. The patient was subsequently discharged without tetany and has since been monitored without the need for calcium or vitamin D supplementation. This case highlights that the COVID-19 infection following a total thyroidectomy can cause hypocalcemia. Postoperative hypocalcemia is a common issue in head and neck surgery, and viral infections like COVID-19 should be considered in the differential diagnosis of hypocalcemia.

摘要

新型冠状病毒肺炎(COVID-19)可导致多种并发症,包括严重的呼吸道症状。病毒感染和全甲状腺切除术均已知会导致低钙血症,因此甲状腺切除术史是COVID-19患者发生低钙血症的一个潜在危险因素。我们报告一例34岁患有格雷夫斯病的女性病例,该患者在全甲状腺切除术后因COVID-19而发生低钙血症。患者接受了顺利的全甲状腺切除术,保留了四个甲状旁腺中的至少三个。术后,她的甲状旁腺激素(PTH)水平正常,且未发生手足搐搦即出院。然而,在术后第90天,她在感染COVID-19期间出现了轻度低钙血症,尽管无症状。到术后第127天,她出现了严重的手足搐搦和全身不适。检测证实再次感染了严重急性呼吸综合征冠状病毒2(SARS-CoV-2)且存在低钙血症,而PTH水平仍正常。静脉注射葡萄糖酸钙、口服乳酸钙和阿法骨化醇治疗有效缓解了低钙血症和手足搐搦。患者随后未再发生手足搐搦而出院,此后一直接受监测,无需补充钙或维生素D。该病例突出表明,全甲状腺切除术后的COVID-19感染可导致低钙血症。术后低钙血症是头颈外科手术中的常见问题,在低钙血症的鉴别诊断中应考虑COVID-19等病毒感染。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4287/11390140/3e10aa739f00/cureus-0016-00000066665-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4287/11390140/8a4f6906a819/cureus-0016-00000066665-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4287/11390140/27f9263aa282/cureus-0016-00000066665-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4287/11390140/a9e4e405b8af/cureus-0016-00000066665-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4287/11390140/3e10aa739f00/cureus-0016-00000066665-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4287/11390140/8a4f6906a819/cureus-0016-00000066665-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4287/11390140/27f9263aa282/cureus-0016-00000066665-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4287/11390140/a9e4e405b8af/cureus-0016-00000066665-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4287/11390140/3e10aa739f00/cureus-0016-00000066665-i04.jpg

相似文献

1
Hypocalcemia Following Thyroidectomy in a Patient With COVID-19: A Case Report and Literature Review.一名新冠肺炎患者甲状腺切除术后的低钙血症:病例报告及文献综述
Cureus. 2024 Aug 12;16(8):e66665. doi: 10.7759/cureus.66665. eCollection 2024 Aug.
2
Postoperative hypocalcemia after thyroidectomy for Graves' disease.甲状腺功能亢进症手术后低钙血症。
Thyroid. 2010 Nov;20(11):1279-83. doi: 10.1089/thy.2010.0047. Epub 2010 Oct 18.
3
Long-term changes in parathyroid function after subtotal thyroidectomy for graves' disease.Graves病甲状腺次全切除术后甲状旁腺功能的长期变化
World J Surg. 2008 Dec;32(12):2612-6. doi: 10.1007/s00268-008-9754-y.
4
COVID-19-Induced Refractory Symptomatic Hypocalcemia in a Patient With Parathyroid Gland Reimplantation.一名甲状旁腺再植患者因新冠病毒感染导致难治性症状性低钙血症
Case Rep Endocrinol. 2024 Sep 24;2024:6375828. doi: 10.1155/2024/6375828. eCollection 2024.
5
Serum parathyroid hormone concentration measured by highly sensitive assay in post-thyroidectomy hypocalcemia of patients with Graves' disease.采用高敏检测法测定格雷夫斯病患者甲状腺切除术后低钙血症时的血清甲状旁腺激素浓度。
Endocrinol Jpn. 1989 Apr;36(2):281-8. doi: 10.1507/endocrj1954.36.281.
6
Treatment of severe life threatening hypocalcemia with recombinant human teriparatide in patients with postoperative hypoparathyroidism - a case series.重组人特立帕肽治疗术后甲状旁腺功能减退患者严重危及生命的低钙血症——病例系列
Endokrynol Pol. 2016;67(4):403-12. doi: 10.5603/EP.a2016.0051. Epub 2016 Jul 8.
7
Prediction of long-term dependence on vitamin D analogues following total thyroidectomy for Graves' disease.预测 Graves 病行甲状腺全切除术患者长期依赖维生素 D 类似物的情况。
Ann R Coll Surg Engl. 2023 Feb;105(2):157-161. doi: 10.1308/rcsann.2022.0007. Epub 2022 Apr 21.
8
The utility of intact parathyroid hormone level in managing hypocalcemia after thyroidectomy in children.完整甲状旁腺激素水平在儿童甲状腺切除术后低钙血症管理中的作用。
Int J Pediatr Otorhinolaryngol. 2019 Oct;125:153-158. doi: 10.1016/j.ijporl.2019.07.006. Epub 2019 Jul 12.
9
4-Hour postoperative PTH level predicts hypocalcemia after thyroidectomy in children.4 小时术后甲状旁腺激素水平可预测儿童甲状腺切除术后低钙血症。
J Pediatr Surg. 2020 Jul;55(7):1265-1269. doi: 10.1016/j.jpedsurg.2019.11.014. Epub 2019 Dec 16.
10
Significant role of 1,25-dihydroxyvitamin D on serum calcium levels after total thyroidectomy: a prospective cohort study.1,25-二羟维生素 D 在全甲状腺切除术后血清钙水平中的重要作用:一项前瞻性队列研究。
Front Endocrinol (Lausanne). 2024 May 13;15:1360464. doi: 10.3389/fendo.2024.1360464. eCollection 2024.

本文引用的文献

1
COVID-19 infection with severe hypocalcaemia and superior mesenteric artery syndrome-a case report.新冠病毒感染合并严重低钙血症及肠系膜上动脉综合征——一例报告
AME Case Rep. 2024 Mar 22;8:54. doi: 10.21037/acr-23-106. eCollection 2024.
2
Assessing Symptomatic Hypocalcemia Risk After Total Thyroidectomy: A Prospective Study.全甲状腺切除术后有症状性低钙血症风险评估:一项前瞻性研究。
Int Arch Otorhinolaryngol. 2024 Feb 5;28(1):e12-e21. doi: 10.1055/s-0043-1777450. eCollection 2024 Jan.
3
Fahr Syndrome Presenting With Status Epilepticus After COVID-19 Infection.
新型冠状病毒肺炎感染后以癫痫持续状态为表现的 Fahr 综合征
JCEM Case Rep. 2023 Jun 28;1(3):luad072. doi: 10.1210/jcemcr/luad072. eCollection 2023 May.
4
Incidental diagnosis of Fahr's syndrome after coronavirus disease 2019 infection with the fatal outcome.2019冠状病毒病感染后偶然诊断出法尔综合征并导致致命后果。
Hippokratia. 2022 Oct-Dec;26(4):161.
5
Association between Hypocalcemia and Outcome in COVID-19 Patients: A Retrospective Study.新冠病毒肺炎患者低钙血症与预后的相关性:一项回顾性研究
J Lab Physicians. 2022 Oct 20;15(2):187-193. doi: 10.1055/s-0042-1757415. eCollection 2023 Jun.
6
Unrecognized Primary Hypoparathyroidism with Severe Hypocalcemia in the Presence of COVID-19 Infection.新型冠状病毒肺炎感染时未被识别的原发性甲状旁腺功能减退症伴严重低钙血症
Acta Med Litu. 2022;29(1):136-143. doi: 10.15388/Amed.2021.29.1.9. Epub 2022 Mar 15.
7
Fahr's Syndrome for Primary Hypoparathyroidism in a Patient With COVID-19.一名新冠肺炎患者原发性甲状旁腺功能减退伴发 Fahr 综合征
Cureus. 2022 Jun 26;14(6):e26342. doi: 10.7759/cureus.26342. eCollection 2022 Jun.
8
Hypocalcemia in hospitalized patients with COVID-19: roles of hypovitaminosis D and functional hypoparathyroidism.COVID-19 住院患者低钙血症:维生素 D 缺乏和功能性甲状旁腺功能减退症的作用。
J Bone Miner Metab. 2022 Jul;40(4):663-669. doi: 10.1007/s00774-022-01330-w. Epub 2022 May 31.
9
COVID-19 induced hypoparathyroidism: A case report.新型冠状病毒肺炎所致甲状旁腺功能减退症:一例报告
Exp Ther Med. 2022 May;23(5):346. doi: 10.3892/etm.2022.11276. Epub 2022 Mar 23.
10
Hypocalcemia in COVID-19: Prevalence, clinical significance and therapeutic implications.新型冠状病毒肺炎相关低钙血症:患病率、临床意义及治疗影响。
Rev Endocr Metab Disord. 2022 Apr;23(2):299-308. doi: 10.1007/s11154-021-09655-z. Epub 2021 Apr 13.